Clinical Trial Update: A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation [Phase 3]

View source ↗

Summary

Phase 3 trial update on sedation using HSK3486 injectable emulsion in ICU patients on mechanical ventilation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation in Intensive Care

Drugs mentioned

• HSK3486 (HSK3486)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Sedation in Intensive Care | Phase 3 | Status: COMPLETED